Incyte Corp
NASDAQ:INCY

Watchlist Manager
Incyte Corp Logo
Incyte Corp
NASDAQ:INCY
Watchlist
Price: 71.325 USD 1.33% Market Closed
Market Cap: 13.7B USD
Have any thoughts about
Incyte Corp?
Write Note

Wall Street
Price Targets

INCY Price Targets Summary
Incyte Corp

Wall Street analysts forecast INCY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INCY is 78.786 USD with a low forecast of 52.52 USD and a high forecast of 101.85 USD.

Lowest
Price Target
52.52 USD
26% Downside
Average
Price Target
78.786 USD
10% Upside
Highest
Price Target
101.85 USD
43% Upside

INCY Last Price Targets
Incyte Corp

The latest public price target was made on Oct 30, 2024 by Jay Olson from Oppenheimer , who expects INCY stock to rise by 15% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Jay Olson
Oppenheimer
82 USD
Upside 15%
3 weeks ago
Oct 30, 2024
Incyte price target raised to $82 from $81 at Oppenheimer
TheFly
Aaron Kessler
Seaport Global
200 USD
Upside 180%
3 weeks ago
Oct 30, 2024
This Alphabet Analyst Turns Bullish; Here Are Top 5 Downgrades For Wednesday
Benzinga
David Lebowitz
Citigroup
97 USD
Upside 36%
3 weeks ago
Oct 30, 2024
Incyte (INCY) PT Raised to $97 at Citi
StreetInsider
Tazeen Ahmad
Bank of America Securities
90 USD
Upside 26%
3 weeks ago
Oct 29, 2024
BofA Securities Upgrades Incyte (INCY) to Buy
StreetInsider
Kelly Shi
Jefferies
84 USD
Upside 18%
3 weeks ago
Oct 29, 2024
Incyte (INCY) PT Raised to $84 at Jefferies
StreetInsider
Andy Chen
Wolfe Research
84 USD
Upside 18%
1 month ago
Sep 30, 2024
Wolfe Research starts Incyte at Outperform amid 'major push' in I&I
TheFly
Tazeen Ahmad
Bank of America Securities
68 USD
Downside 5%
2 months ago
Sep 16, 2024
Incyte (INCY) PT Raised to $68 at BofA Securities
StreetInsider
Salveen Richter
Goldman Sachs
60 USD
Downside 16%
2 months ago
Sep 16, 2024
Goldman Sachs Reiterates Neutral Rating on Incyte (INCY)
StreetInsider
David Lebowitz
Citigroup
92 USD
Upside 29%
3 months ago
Aug 18, 2024
Incyte price target raised to $92 from $88 at Citi
TheFly
Brian Abrahams
RBC Capital
66 USD
Downside 7%
3 months ago
Jul 31, 2024
Incyte price target raised to $66 from $61 at RBC Capital
TheFly
Jay Olson
Oppenheimer
81 USD
Upside 14%
3 months ago
Jul 26, 2024
Incyte price target lowered to $81 from $84 at Oppenheimer
TheFly
Evan Seigerman
BMO Capital
48 USD
Downside 33%
4 months ago
Jul 2, 2024
BMO Capital Downgrades Incyte (INCY) to Underperform
StreetInsider
James Shin
Deutsche Bank
55 USD
Downside 23%
5 months ago
May 23, 2024
Incyte initiated with a Hold at Deutsche Bank
TheFly
Evan David Seigerman
BMO Capital
52 USD
Downside 27%
6 months ago
Apr 30, 2024
Incyte (INCY) PT Lowered to $52 at BMO Capital
StreetInsider
Jasper Hellweg
Argus Research
70 USD
Downside 2%
6 months ago
Apr 25, 2024
Incyte price target lowered to $70 from $80 at Argus
TheFly
Unknown Analyst
Cowen & Co.
100 USD
Upside 40%
1 year ago
Feb 8, 2023
Cowen & Co. Maintains Outperform on Incyte, Raises Price Target to $100
Benzinga
Show More Price Targets
Show Less Price Targets
Jay Olson
Oppenheimer
Price Target 82 USD
Upside/Downside 15%
View Source
Aaron Kessler
Seaport Global
Price Target 200 USD
Upside/Downside 180%
View Source
David Lebowitz
Citigroup
Price Target 97 USD
Upside/Downside 36%
View Source
Tazeen Ahmad
Bank of America Securities
Price Target 90 USD
Upside/Downside 26%
View Source
Kelly Shi
Jefferies
Price Target 84 USD
Upside/Downside 18%
View Source
Andy Chen
Wolfe Research
Price Target 84 USD
Upside/Downside 18%
View Source
Tazeen Ahmad
Bank of America Securities
Price Target 68 USD
Upside/Downside 5%
View Source
Salveen Richter
Goldman Sachs
Price Target 60 USD
Upside/Downside 16%
View Source
David Lebowitz
Citigroup
Price Target 92 USD
Upside/Downside 29%
View Source
Brian Abrahams
RBC Capital
Price Target 66 USD
Upside/Downside 7%
View Source
Jay Olson
Oppenheimer
Price Target 81 USD
Upside/Downside 14%
View Source
Evan Seigerman
BMO Capital
Price Target 48 USD
Upside/Downside 33%
View Source
James Shin
Deutsche Bank
Price Target 55 USD
Upside/Downside 23%
View Source
Evan David Seigerman
BMO Capital
Price Target 52 USD
Upside/Downside 27%
View Source
Jasper Hellweg
Argus Research
Price Target 70 USD
Upside/Downside 2%
View Source
Unknown Analyst
Cowen & Co.
Price Target 100 USD
Upside/Downside 40%
View Source
Show More Price Targets
Show Less Price Targets
Incyte Corp Competitors:
Price Targets
PRQR
ProQR Therapeutics NV
89% Upside
TGTX
TG Therapeutics Inc
15% Upside
BBIO
BridgeBio Pharma Inc
108% Upside
DVAX
Dynavax Technologies Corp
95% Upside
HALO
Halozyme Therapeutics Inc
30% Upside
NRIX
Nurix Therapeutics Inc
42% Upside
RXRX
Recursion Pharmaceuticals Inc
76% Upside
UTHR
United Therapeutics Corp
8% Upside

Revenue
Forecast

Revenue Estimate
Incyte Corp

For the last 8 years the compound annual growth rate for Incyte Corp's revenue is 22%. The projected CAGR for the next 3 years is 12%.

22%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Incyte Corp

For the last 8 years the compound annual growth rate for Incyte Corp's operating income is 38%. The projected CAGR for the next 3 years is 41%.

38%
Past Growth
41%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Net Income
Forecast

Net Income Estimate
Incyte Corp

For the last 8 years the compound annual growth rate for Incyte Corp's net income is 76%. The projected CAGR for the next 3 years is 37%.

76%
Past Growth
37%
Estimated Growth
Estimates Accuracy
-15%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INCY's stock price target?
Price Target
78.786 USD

According to Wall Street analysts, the average 1-year price target for INCY is 78.786 USD with a low forecast of 52.52 USD and a high forecast of 101.85 USD.

What is Incyte Corp's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Incyte Corp's revenue is 22%. The projected CAGR for the next 3 years is 12%.

What is Incyte Corp's Operating Income forecast?
Projected CAGR
41%

For the last 8 years the compound annual growth rate for Incyte Corp's operating income is 38%. The projected CAGR for the next 3 years is 41%.

What is Incyte Corp's Net Income forecast?
Projected CAGR
37%

For the last 8 years the compound annual growth rate for Incyte Corp's net income is 76%. The projected CAGR for the next 3 years is 37%.

Back to Top